Novel Targeting of Transcription and Metabolism in Glioblastoma

PURPOSE: Glioblastoma (GBM) is highly resistant to treatment, largely due to disease heterogeneity and resistance mechanisms. We sought to investigate a promising drug that can inhibit multiple aspects of cancer cell survival mechanisms and become an effective therapeutic for GBM patients. EXPERIMEN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Su, Yu-Ting, Chen, Robert, Wang, Herui, Song, Hua, Zhang, Qi, Chen, Li-Yuan, Lappin, Hallie, Vasconcelos, Gabriel, Lita, Adrian, Maric, Dragan, Li, Aiguo, Celiku, Orieta, Zhang, Wei, Meetze, Kristan, Estok, Thomas, Larion, Mioara, Abu-Asab, Mones, Zhuang, Zhengping, Yang, Chunzhang, Gilbert, Mark R., Wu, Jing
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108069/
https://ncbi.nlm.nih.gov/pubmed/29254993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-2032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados